AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2013
Aug 8, 2013
32939_dirs_2013-08-08_c6af6e4d-de09-481f-9718-718f6f70dfaf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2013-08-06
Reporting Person: Bourne George W. IV (CTO and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-06 | Common Stock | A | 6055 | — | Acquired | 18018 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-08-06 | Non-Qualified Stock Option (right to buy) | $11.92 | A | 19723 | Acquired | 2020-08-06 | Common Stock (19723) | Direct |
Footnotes
F1: The acquisition of 6,055 shares of common stock represents 6,055 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal installments beginning on 8/6/2014.
F2: Options for 25% of the shares are each exercisable on 8/6/2014, 8/6/2015, 8/6/2016 and 8/6/2017, respectively.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6